Gossypol inhibits calcineurin phosphatase activity at multiple sites

European Journal of Pharmacology

Volumn 555, Issue 2-3, 2007, Pages 106-114

  Carruthers, Nicholas J ^a   Dowd, Michael K ^b   Stemmer, Paul M ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b SOUTHERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Calcineurin; Calmodulin; Domain; Enantiomer; Gossypol

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; GOSSYPOL; IMMUNOPHILIN; IMMUNOSUPPRESSIVE AGENT; POLYPHENOL; PROTEIN KINASE (CALCIUM,CALMODULIN); TACROLIMUS;

ARTICLE; CYTOTOXICITY; DRUG INHIBITION; ENZYME ACTIVITY; FLUORESCENCE POLARIZATION; NONHUMAN; PRIORITY JOURNAL; STEREOSPECIFICITY;

ANIMALS; CALCINEURIN; CALMODULIN; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; GOSSYPOL; MUSCLE, SKELETAL; PEPTIDES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; RABBITS;

EID: 33845975586     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.10.046     Document Type: Article

References (51)

1. Aramburu J., Yaffe M.B., Lopez-Rodriguez C., Cantley L.C., Hogan P.G., and Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285 (1999) 2129-2133
2. Baba Y., Hirukawa N., Tanohira N., and Sodeoka M. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). J. Am. Chem. Soc. 125 (2003) 9740-9749
3. Baba Y., Hirukawa N., and Sodeoka M. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode. Bioorg. Med. Chem. 13 (2005) 5164-5170
4. Band V., Hoffer A.P., Band H., Rhinehardt A.E., Knapp R.C., Matlin S.A., and Anderson D.J. Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol. Oncol. 32 (1989) 273-277
5. Baumgrass R., Weiwad M., Erdmann F., Liu J.O., Wunderlich D., Grabley S., and Fischer G. Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol. J. Biol. Chem. 276 (2001) 47914-47921
6. Baumgrass R., Zhang Y., Erdmann F., Thiel A., Weiwad M., Radbruch A., and Fischer G. Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression. J. Biol. Chem. 279 (2004) 2470-2479
7. Benz C.C., Keniry M.A., Ford J.M., Townsend A.J., Cox F.W., Palayoor S., Matlin S.A., Hait W.N., and Cowan K.H. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol. Pharmacol. 37 (1990) 840-847
8. Blumenthal D.K., Takio K., Hansen R.S., and Krebs E.G. Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. J. Biol. Chem. 261 (1986) 8140-8145
9. Cardoso S.M., and Oliveira C.R. The role of calcineurin in amyloid-beta-peptides-mediated cell death. Brain Res. 1050 (2005) 1-7
10. Carmody M., Mackrill J.J., Sorrentino V., and O'Neill C. FKBP12 associates tightly with the skeletal muscle type 1 ryanodine receptor, but not with other intracellular calcium release channels. FEBS Lett. 505 (2001) 97-102
11. Checovich W.J., Bolger R.E., and Burke T. Fluorescence polarization-a new tool for cell and molecular biology. Nature 375 (1995) 254-256
12. Clauser K.R., Baker P., and Burlingame A.L. Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71 (1999) 2871-2882
13. Coghlan V.M., Perrino B.A., Howard M., Langeberg L.K., Hicks J.B., Gallatin W.M., and Scott J.D. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267 (1995) 108-111
14. Coutinho E.M., Athayde C., Atta G., Gu Z.P., Chen Z.W., Sang G.W., Emuveyan E., Adekunle A.O., Mati J., Otubu J., Reidenberg M.M., and Segal S.J. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study. Contraception 61 (2000) 61-67
15. Dowd M.K. Preparation of enantiomeric gossypol by crystallization. Chirality 15 (2003) 486-493
16. Duronio R.J., Jackson-Machelski E., Heuckeroth R.O., Olins P.O., Devine C.S., Yonemoto W., Slice L.W., Taylor S.S., and Gordon J.I. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1506-1510
17. Enz A., and Pombo-Villar E. Class II pyrethroids: noninhibitors calcineurin. Biochem. Pharmacol. 54 (1997) 321-323
18. Fakata K.L., Swanson S.A., Vorce R.L., and Stemmer P.M. Pyrethroid insecticides as phosphatase inhibitors. Biochem. Pharmacol. 55 (1998) 2017-2022
19. Feng B., and Stemmer P.M. Ca2+ binding site 2 in calcineurin-B modulates calmodulin-dependent calcineurin phosphatase activity. Biochemistry 40 (2001) 8808-8814
20. Fiedler B., and Wollert K.C. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc. Res. 63 (2004) 450-457
21. Finlay T.H., Dharmgrongartama E.D., and Perlmann G.E. Mechanism of the gossypol inactivation of pepsinogen. J. Biol. Chem. 248 (1973) 4827-4833
22. Groth R.D., Dunbar R.L., and Mermelstein P.G. Calcineurin regulation of neuronal plasticity. Biochem. Biophys. Res. Commun. 311 (2003) 1159-1171
23. Huai Q., Kim H.Y., Liu Y., Zhao Y., Mondragon A., Liu J.O., and Ke H. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12037-12042
24. Hubbard M.J., and Klee C.B. Functional domain structure of calcineurin A: mapping by limited proteolysis. Biochemistry 28 (1989) 1868-1874
25. Jinsart W., Ternai B., and Polya G.M. Inhibition of wheat embryo calcium-dependent protein kinase and avian myosin light chain kinase by flavonoids and related compounds. Biol. Chem. Hoppe-Seyler 372 (1991) 819-827
26. Joseph A.E., Matlin S.A., and Knox P. Cytotoxicity of enantiomers of gossypol. Br. J. Cancer 54 (1986) 511-513
27. Kalla N.R., and Sud S. Distribution of gossypol. Acta Eur. Fertil. 21 (1990) 77-80
28. Kim H.L., Calhoun M.C., and Stipanovic R.D. Accumulation of gossypol enantiomers in ovine tissues. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 113 (1996) 417-420
29. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W., et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378 (1995) 641-644
30. Li H., Rao A., and Hogan P.G. Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. J. Mol. Biol. 342 (2004) 1659-1674
31. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
32. Maugh II T.H. Male "pill" blocks sperm enzyme. Science 212 (1981) 314
33. Mayr G.W., Windhorst S., and Hillemeier K. Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol-1,4,5-trisphosphate 3-kinases and inositol polyphosphate multikinase. J. Biol. Chem. 280 (2005) 13229-13240
34. Mondragon A., Griffith E.C., Sun L., Xiong F., Armstrong C., and Liu J.O. Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry 36 (1997) 4934-4942
35. Montigiani S., Neri G., Neri P., and Neri D. Alanine substitutions in calmodulin-binding peptides result in unexpected affinity enhancement. J. Mol. Biol. 258 (1996) 6-13
36. Perrino B.A. Regulation of calcineurin phosphatase activity by its autoinhibitory domain. Arch. Biochem. Biophys. 372 (1999) 159-165
37. Persechini A., Jarrett H.W., Kosk-Kosicka D., Krinks M.H., and Lee H.G. Activation of enzymes by calmodulins containing intramolecular cross-links. Biochim. Biophys. Acta 1163 (1993) 309-314
38. Phillis J.W., Diaz F.G., O'Regan M.H., and Pilitsis J.G. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Brain Res. 957 (2002) 12-24
39. Santini M.P., Talora C., Seki T., Bolgan L., and Dotto G.P. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9575-9580
40. Schreiber S.L., and Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13 (1992) 136-142
41. Serfling E., Berberich-Siebelt F., Chuvpilo S., Jankevics E., Klein-Hessling S., Twardzik T., and Avots A. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim. Biophys. Acta 1498 (2000) 1-18
42. Shelley M.D., Hartley L., Fish R.G., Groundwater P., Morgan J.J., Mort D., Mason M., and Evans A. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett. 135 (1999) 171-180
43. Sommer D., Fakata K.L., Swanson S.A., and Stemmer P.M. Modulation of the phosphatase activity of calcineurin by oxidants and antioxidants in vitro. Eur. J. Biochem. 267 (2000) 2312-2322
44. Sommer D., Coleman S., Swanson S.A., and Stemmer P.M. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch. Biochem. Biophys. 404 (2002) 271-278
45. Stemmer P.M., and Klee C.B. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry 33 (1994) 6859-6866
46. Stemmer P.M., Wang X., Krinks M.H., and Klee C.B. Factors responsible for the Ca(2+)-dependent inactivation of calcineurin in brain. FEBS Lett. 374 (1995) 237-240
47. Van Poznak C., Seidman A.D., Reidenberg M.M., Moasser M.M., Sklarin N., Van Zee K., Borgen P., Gollub M., Bacotti D., Yao T.J., Bloch R., Ligueros M., Sonenberg M., Norton L., and Hudis C. Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res. Treat. 66 (2001) 239-248
48. Waller D.P., Bunyapraphatsara N., Martin A., Vournazos C.J., Ahmed M.S., Soejarto D.D., Cordell G.A., Fong H.H., Russell L.D., and Malone J.P. Effect of (+)-gossypol on fertility in male hamsters. J. Androl. 4 (1983) 276-279
49. Wang X., Culotta V.C., and Klee C.B. Superoxide dismutase protects calcineurin from inactivation. Nature 383 (1996) 434-437
50. Weissenmayer B., Boelckeler K., Lahrz A., and Mutzel R. The calcineurin inhibitor gossypol impairs growth, cell signalling and development in Dictyostelium discoideum. FEMS Microbiol. Lett. 242 (2005) 19-25
51. Yu B.Z., Rogers J., Ranadive G., Baker S., Wilton D.C., Apitz-Castro R., and Jain M.K. Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates. Biochemistry 36 (1997) 12400-12411